Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author GASCON, Maria Rita Polo FMUSP-HC
CAPITAO, Claudio Garcia
CASSEB, Jorge FMUSP-HC
NOGUEIRA-MARTINS, Maria Cezira Fantini
SMID, Jerusa
OLIVEIRA, Augusto Cesar Penalva de
dc.date.issued 2011
dc.identifier.citation BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.15, n.6, p.578-582, 2011
dc.identifier.issn 1413-8670
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/24159
dc.description.abstract The HAM/TSP caused by HTLV-1 infection usually affects patients to disabling states, and sometimes can lead them to paraplegia presenting symptoms of depression and anxiety, impacting on quality of life. Objective: The purpose of this study was to evaluate the frequency of depression and anxiety and its impact on quality of life in HTLV-1-infected TSP/HAM patients. Material and Methods: This was a cross-sectional study including 67 asymptomatic (control group) and 63 with TSP/HAM subjects. The instruments used were a demographic questionnaire, scales for anxiety and depression diagnosis (BDI and BAI), questionnaire for the assessment of Quality of Life of the World Health Organization (WHOQOL-Brief) and neurological scale to measure the disability level (Osame's Disability Status Scale). All patients had HTLV-I diagnosis by serological and molecular approaches, monitored at Instituto de Infectologia Emilio Ribas from May 2008 to July 2009. Data were analyzed statistically by frequencies, the Mann-Whitney test and the Spearman correlation test. Data among groups were analyzed and correlated with functional and severity aspects. Results: The results showed that patients with HAM/TSP compared to asymptomatic carriers had higher rates of depression (p < 0.001) and anxiety (p < 0.001), and impairment on quality of life in the areas of: dissatisfaction with health (p < 0.001), physical (p < 0.001) and the environment (p = 0.003). The main factors that correlated with levels of depression and anxiety and the domains of the WHOQOL-brief were: education, family income and social class. Conclusion: A well conducted evaluation and counseling may help in treatment, for a better quality of life of these patients.
dc.description.sponsorship · FAPESP e Coordenadoria de Controle de Doencas CCD/SES-SP
dc.language.iso eng
dc.publisher CONTEXTO
dc.relation.ispartof Brazilian Journal of Infectious Diseases
dc.rights openAccess
dc.subject anxiety; depression; quality of life; human T-lymphotropic virus 1
dc.subject.other virus type-i; brazil
dc.title Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients
dc.type article
dc.rights.holder Copyright CONTEXTO
dc.description.group LIM/56
dc.identifier.pmid 22218518
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author GASCON, Maria Rita Polo:HC:ICHC
hcfmusp.author CASSEB, Jorge:IMT:IMT
hcfmusp.author.external · NOGUEIRA-MARTINS, Maria Cezira Fantini:Inst Saude Sao Paulo, Sao Paulo, SP, Brazil
· SMID, Jerusa:Univ Sao Paulo, Inst Infectol Emilio Ribas, Hosp Clin, Sao Paulo, SP, Brazil
· OLIVEIRA, Augusto Cesar Penalva de:Santa Casa de Misericordia Sao Paulo, Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil; Univ Estadual Campinas, UNICAMP, BR-13081970 Campinas, SP, Brazil
hcfmusp.origem.id 2-s2.0-84855976310
hcfmusp.origem.id WOS:000298304300012
hcfmusp.publisher.city SALVADOR
hcfmusp.publisher.country BRAZIL
hcfmusp.relation.reference · Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013
· OSAME M, 1986, LANCET, V1, P1031
· Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
· Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012
· Beck A. T., 1961, ARCH GEN PSYCHIAT, V4, P53
· Brasil, 2008, BRASIL AS CAUSAS SOC
· [Brasil. Ministerio da Saude/Secretaria de Politicas de Saude Coordenacao Nacional de DST e AIDS], 2004, COORD NAC DST AIDS G
· Carneiro-Proietti Anna Bárbara F, 2002, Rev Soc Bras Med Trop, V35, P499, DOI 10.1590/S0037-86822002000500013
· Carvalho André Gordilho Joaquim de, 2009, Braz J Infect Dis, V13, P5
· Carvalho SMF, 1997, J ACQ IMMUNE DEFIC S, V15, P238
· Casseb J, PREVALENCIA HTLV I I
· Castro NM, 2007, UROLOGY, V69, P813, DOI 10.1016/j.urology.2007.01.052
· Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81, DOI 10.1590/S1415-790X2001000200003
· Coutinho IJ, 2008, BRAZ J INFECT DIS S, P20
· Cunha J.A., 2001, MANUAL VERSAO PORTUG
· Dancey CP, 2007, ESTATISTICA SEM MATE
· Etzel A, 1999, REV SOC BRAS MED TRO, V32, P735
· GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x
· Shublaq MS, 2009, THESIS U FEDERAL RIO
· Souza ARM, 2009, ARQ NEURO-PSIQUIAT, V67, P365
· Stumpf BP, 2005, AIDS RES HUM RETROV, V21, P465
dc.description.index MEDLINE
hcfmusp.citation.scopus 15
hcfmusp.affiliation.country Brasil
hcfmusp.scopus.lastupdate 2021-07-14


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics